Simple Summary Researchers have shown that tumor biomarkers and increased nerve
density are important clinical tools for determining cancer prognosis and developing …

The dramatic recent advances in therapy of melanoma require a more personalized and
precise diagnostic approach to aid in clinical decisions. Tissue-based biomarkers in …

Background There is no widely employed staging system for mucosal melanoma (MuM) that
incorporates all anatomic sites. We hypothesized that MuM patients arising from different …

Anorectal melanoma is an aggressive mucosal melanoma subtype with a poor prognosis.
Although recent advancements have been seen for cutaneous melanoma, the optimal …

Purpose Primary anorectal melanoma (ARM) accounts for approximately 1.2% of all
melanomas and 16.5% of all mucosal melanomas. ARM is associated with the shortest …

Objective This study aimed to construct prognostic models to predict the overall survival (OS)
and cancer-specific survival (CSS) of patients with primary gastrointestinal melanoma …

Anorectal malignant melanoma (ARMM) is a rare disease with poor prognosis. Determining
ARMM prognosis precisely is difficult due to the lack of proper assessment techniques …

Mucosal melanomas are rare malignant tumors arising from the epithelia lining the inner
mucosal surfaces of the body. Unlike cutaneous melanoma, we have a limited …

Mucosal melanoma remains a rare cancer with high mortality and a paucity of therapeutic
options. This is due in significant part to its low incidence leading to limited patient access to …

Mucosal melanoma is a rare subtype of melanoma that represents only 1.3% of all
melanoma cases 1 and has distinct clinical, biological, and management considerations …